These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 24774593)
1. Update on interventional cardiology 2013. Hernández Hernández F; Rumoroso Cuevas JR; García Del Blanco B; Trillo Nouche R Rev Esp Cardiol (Engl Ed); 2014 Apr; 67(4):305-11. PubMed ID: 24774593 [TBL] [Abstract][Full Text] [Related]
2. 2014 update on interventional cardiology. Hernández Hernández F; de la Torre Hernández JM; Rumoroso Cuevas JR; García del Blanco B; Martínez-Sellés M; Trillo Nouche R Rev Esp Cardiol (Engl Ed); 2015 Apr; 68(4):324-30. PubMed ID: 25749393 [TBL] [Abstract][Full Text] [Related]
3. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
4. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial. Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423 [TBL] [Abstract][Full Text] [Related]
5. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial. Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625 [TBL] [Abstract][Full Text] [Related]
6. Update on interventional cardiology. de la Torre Hernández JM; Díaz Fernández JF; Sabaté Tenas M; Goicolea Ruigomez J Rev Esp Cardiol (Engl Ed); 2013 Apr; 66(4):282-9. PubMed ID: 24775618 [TBL] [Abstract][Full Text] [Related]
7. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected]. Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964 [TBL] [Abstract][Full Text] [Related]
9. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials. Bangalore S; Amoroso N; Fusaro M; Kumar S; Feit F Circ Cardiovasc Interv; 2013 Aug; 6(4):378-90. PubMed ID: 23922145 [TBL] [Abstract][Full Text] [Related]
10. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397 [TBL] [Abstract][Full Text] [Related]
11. Endothelial Dysfunction After ST-segment Elevation Myocardial Infarction and Long-term Outcome: A Study With Reactive Hyperemia Peripheral Artery Tonometry. Kandhai-Ragunath JJ; Doggen CJ; Jørstad HT; Doelman C; de Wagenaar B; IJzerman MJ; Peters RJ; von Birgelen C Rev Esp Cardiol (Engl Ed); 2016 Jul; 69(7):664-71. PubMed ID: 27068872 [TBL] [Abstract][Full Text] [Related]
12. API expert consensus document on management of ischemic heart disease. Association of Physicians of India J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697 [TBL] [Abstract][Full Text] [Related]
13. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial. Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603 [TBL] [Abstract][Full Text] [Related]
14. Appropriate use of noninvasive ischemia testing to guide revascularization decision making following acute ST elevation myocardial infarction in Latin American countries: Results from an expert panel meeting of the International Atomic Energy Agency. Berrocal I; Peix A; Mut F; Shaw LJ; Karthikeyan G; Estrada Lobato E; Paez D Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):237-243. PubMed ID: 29778317 [TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. Laarman GJ; Suttorp MJ; Dirksen MT; van Heerebeek L; Kiemeneij F; Slagboom T; van der Wieken LR; Tijssen JG; Rensing BJ; Patterson M N Engl J Med; 2006 Sep; 355(11):1105-13. PubMed ID: 16971717 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ; Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052 [TBL] [Abstract][Full Text] [Related]
17. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY). Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G; JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420 [TBL] [Abstract][Full Text] [Related]